Cyclacel Pharmaceuticals (CYCC)
(Delayed Data from NSDQ)
$1.62 USD
-0.08 (-4.71%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $1.64 +0.02 (1.23%) 7:10 PM ET
2-Buy of 5 2
F Value B Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.83 | 0.00% |
Earnings Summary
For their last quarter, Cyclacel Pharmaceuticals (CYCC) reported earnings of -$2.27 per share, beating the Zacks Consensus Estimate of $-4.93 per share. This reflects a positive earnings surprise of 53.96%. Look out for CYCC's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year increase of 87.42%.
Earnings History
Price & Consensus
Zacks News for CYCC
New Strong Buy Stocks for October 17th
CYCC: What are Zacks experts saying now?
Zacks Private Portfolio Services